Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...

Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug ...

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...

Hospital margins improved in June as revenue gains outpaced patient volume — but Kaufman Hall’s latest data shows that financial gaps between high- and low-performing organizations persist, with ...

You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and physicians across the country need to be prepared to understand and ...

A new initiative from the Digital Medicine Society aims to replace outdated mental health questionnaires with a set of shared digital measures that track things like patients’ sleep, activity ...

The 2025 Benefits Sentiment Index, a survey of 120 benefit consultants to self-insured employers, focuses on healthcare navigation, GLP-1 drug coverage and AI trends for healthcare benefits.